https://pharmadog.xyz/news/500279 pharmadog en 2026-10-05T16:38:08.000Z Staggering health insurance premiums force employers to rethink coverage options https://pharmadog.xyz/news/500235 pharmadog en 2026-10-05T16:27:02.000Z FDA delays review of Novo's hemophilia A drug denecimig over factory issues https://pharmadog.xyz/news/500111 pharmadog en 2026-10-05T16:00:14.000Z Utah moves forward with AI-driven acne prescription pilot, Nolla Health to test autonomous drug prescribing https://pharmadog.xyz/news/500299 pharmadog en 2026-10-05T15:57:00.000Z Shionogi to acquire Texas-based IntraBio for $2 billion, adding marketed rare-disease drug Aqneursa https://pharmadog.xyz/news/500091 pharmadog en 2026-10-05T15:16:04.000Z Two Massachusetts biotech firms shut down, ending cancer and eye‑disease programs https://pharmadog.xyz/news/500067 pharmadog en 2026-10-05T15:06:23.000Z Vaxcyte's experimental pneumococcal vaccine VAX-31 meets Phase 3 endpoints, shares jump 35% https://pharmadog.xyz/news/500068 pharmadog en 2026-10-05T15:02:14.000Z Genmab reports 45.9% response rate for FRα‑directed ADC in platinum‑resistant ovarian cancer; Lilly expands Jaypirca label https://pharmadog.xyz/news/500092 pharmadog en 2026-10-05T15:01:53.000Z Lilly adds $870M to Gate Bioscience partnership to pursue new drug targets https://pharmadog.xyz/news/499923 pharmadog en 2026-10-05T14:36:02.000Z Genentech signs up to develop Alector’s preclinical blood-brain barrier therapy in $1.27 billion deal https://pharmadog.xyz/news/499899 pharmadog en 2026-10-05T14:30:01.000Z Roche signs $100 million upfront deal with Alector to advance Parkinson's research https://pharmadog.xyz/news/499900 pharmadog en 2026-10-05T14:19:13.000Z Shionogi agrees $2 billion upfront purchase of IntraBio, adding oral rare-disease drug Aqneursa to its portfolio https://pharmadog.xyz/news/499901 pharmadog en 2026-10-05T14:00:22.000Z Report highlights 20 women reshaping biopharma across oncology and rare disease fields https://pharmadog.xyz/news/500131 pharmadog en 2026-10-05T13:57:00.000Z Nobel Prize honors optogenetics pioneers; Roche licenses Alector’s Parkinson’s enzyme therapy https://pharmadog.xyz/news/499775 pharmadog en 2026-10-05T13:55:41.000Z Eli Lilly's Jaypirca receives FDA approval for first-line treatment of untreated CLL and SLL https://pharmadog.xyz/news/499795 pharmadog en 2026-10-05T13:52:00.000Z Vaxcyte's next-gen pneumococcal vaccine matches leading shots in Phase 3 trial https://pharmadog.xyz/news/499755 pharmadog en 2026-10-05T13:32:51.000Z CSL strikes up to $1.6B deal with Alentis for autoimmune drug with broad potential https://pharmadog.xyz/news/499756 pharmadog en 2026-10-05T13:25:55.000Z Biogen's litifilimab shows clear or almost clear skin in cutaneous lupus after one year https://pharmadog.xyz/news/499757 pharmadog en 2026-10-05T13:23:59.000Z Vaxcyte’s VAX-31 shows superior results in Phase 3, beating Pfizer and Merck’s pneumococcal vaccines and sparking $8 bn market hopes https://pharmadog.xyz/news/499776 pharmadog en 2026-10-05T13:10:03.000Z Vaxcyte’s pneumococcal vaccine meets primary goals in Phase 3 trial, challenging Pfizer and Merck https://pharmadog.xyz/news/499982 pharmadog en 2026-10-05T13:02:06.000Z FDA issues request for information on early-phase ibogaine trial design https://pharmadog.xyz/news/499607 pharmadog en 2026-10-05T12:19:11.000Z Vaxcyte's experimental pneumococcal vaccine meets primary endpoints in Phase 3 trial https://pharmadog.xyz/news/499608 pharmadog en 2026-10-05T12:00:51.000Z 2026 Nobel Prize awarded to U.S. and German scientists for optogenetics breakthroughs https://pharmadog.xyz/news/499395 pharmadog en 2026-10-05T11:08:36.000Z Nobel prize honors scientists who pioneered light-activated gene therapy technology https://pharmadog.xyz/news/499396 pharmadog en 2026-10-05T11:00:27.000Z Sensible Bio raises $47 million Series A to build mRNA therapy manufacturing platform https://pharmadog.xyz/news/499397 pharmadog en 2026-10-05T11:00:22.000Z Epicrispr reports encouraging early data from EPI-321 in 12 patients with FSHD https://pharmadog.xyz/news/499874 pharmadog en 2026-10-05T10:09:00.000Z Genentech pays Alector $100M for preclinical Parkinson’s prospect https://pharmadog.xyz/news/499103 pharmadog en 2026-10-05T10:00:11.000Z 2026 Nobel Prize in Medicine awarded for optogenetics, the light-controlled brain research tool https://pharmadog.xyz/news/499015 pharmadog en 2026-10-05T09:00:00.000Z Diagnostic-driven therapies face patient loss due to workflow gaps, new commercialization model proposed https://pharmadog.xyz/news/499016 pharmadog en 2026-10-05T09:00:00.000Z AI drives faster drug development and reshapes biopharma manufacturing facilities https://pharmadog.xyz/news/498829 pharmadog en 2026-10-05T08:30:00.000Z Late-stage mRNA melanoma vaccine shows promise, slowing disease recurrence https://pharmadog.xyz/news/498830 pharmadog en 2026-10-05T08:30:00.000Z Rising Hospital and Drug Prices Drive Up Insurance Premiums for Workers and Employers https://pharmadog.xyz/news/498831 pharmadog en 2026-10-05T08:30:00.000Z Energy drinks partner with college sports, raising safety concerns for teens https://pharmadog.xyz/news/498828 pharmadog en 2026-10-05T08:30:00.000Z Will AI like Claude ever earn a Nobel Prize in medicine? https://pharmadog.xyz/news/498827 pharmadog en 2026-10-05T08:30:00.000Z Stem cell advocates anticipate FDA roundtables as peptide therapies gain regulatory foothold https://pharmadog.xyz/news/499538 pharmadog en 2026-10-05T08:16:00.000Z Vaxcyte’s 31-valent pneumococcal vaccine shows non-inferior immunity to Pfizer and Merck shots in Phase 3, shares surge https://pharmadog.xyz/news/499371 pharmadog en 2026-10-05T06:40:00.000Z Scientists awarded 2026 Nobel Prize for pioneering optogenetics light-switch technique https://pharmadog.xyz/news/498135 pharmadog en 2026-10-05T04:44:00.000Z Kyverna Therapeutics reports encouraging data for first CAR-T therapy targeting autoimmune disease https://pharmadog.xyz/news/499036 pharmadog en 2026-10-05T04:16:00.000Z CSL pays $355M upfront to co-develop Alentis’ phase-2 fibrosis drug lixudebart https://pharmadog.xyz/news/498759 pharmadog en 2026-10-05T04:15:00.000Z Genmab’s Rina-S ADC shows 9.5-month median PFS, touted as superior to AbbVie’s Elahere https://pharmadog.xyz/news/498136 pharmadog en 2026-10-05T04:03:00.000Z Roivant Sciences launches first solo drug, Lisraya, after FDA approval for dermatomyositis https://pharmadog.xyz/news/498137 pharmadog en 2026-10-05T04:02:00.000Z FDA urged to boost US access to new and experimental drugs as trials shift to China https://pharmadog.xyz/news/498138 pharmadog en 2026-10-05T04:01:00.000Z Swiss CDMOs and CROs experience rapid growth as global sponsors seek specialized manufacturing and decentralized trials https://pharmadog.xyz/news/497775 pharmadog en 2026-10-05T02:22:24.000Z CSL agrees $355M upfront deal to co-develop Alentis anti-fibrosis drug for kidney and liver https://pharmadog.xyz/news/499713 pharmadog en 2026-10-05T02:04:00.000Z FDA approves first expandable pediatric pulmonary heart valve https://pharmadog.xyz/news/495707 pharmadog en 2026-10-04T16:58:12.000Z Trump pledges $90 one-time Medicare Part B premium payment to over 20 million seniors before midterms